RU94022194A - Medicinal agent base - Google Patents

Medicinal agent base

Info

Publication number
RU94022194A
RU94022194A RU94022194/14A RU94022194A RU94022194A RU 94022194 A RU94022194 A RU 94022194A RU 94022194/14 A RU94022194/14 A RU 94022194/14A RU 94022194 A RU94022194 A RU 94022194A RU 94022194 A RU94022194 A RU 94022194A
Authority
RU
Russia
Prior art keywords
liquid
drug
therapeutic effect
medicinal agent
mass
Prior art date
Application number
RU94022194/14A
Other languages
Russian (ru)
Inventor
Ю.Е. Беляев
В.А. Власов
Original Assignee
АОЗТ "Научно-практический центр медикобиологических проблем"
АО "Кормист"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by АОЗТ "Научно-практический центр медикобиологических проблем", АО "Кормист" filed Critical АОЗТ "Научно-практический центр медикобиологических проблем"
Priority to RU94022194/14A priority Critical patent/RU94022194A/en
Publication of RU94022194A publication Critical patent/RU94022194A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

FIELD: medicine, therapy, pharmacy. SUBSTANCE: invention can be employed as an initial component for different medicinal agents preparing showing therapeutic effect. Also, the base of medicinal agent can be used as an independent medicinal agent showing high therapeutic effect. The base of proposed medicinal agent is placental material with liquid. Placental material with liquid is prepared as sour cream-like mass. Content and state of the sour cream-like mass is given in variants. EFFECT: improved quality, properties and effectiveness of agent, prolonged activity at storage.

Claims (1)

Изобретение относится к медицине, конкретно к терапии и может служить исходным компонентом для приготовления лекарственных средств различного назначения, обладающих терапевтическим эффектом. Предлагаемое техническое решение позволяет создать основу лекарственного средства с однородным и равномерным распределением по массе и объему биологически активных веществ, которые обладают способностью сохранять свою активность длительное время. Кроме того, это техническое решение позволяет получить основу лекарственного средства, которое может быть и самостоятельным лекарственным средством, обладающим высоким терапевтическим эффектом. Известна основа лекарственного средства, содержащая плацентарный материал с жидкостью. Новым является то, что плацентарный материал с жидкостью выполнен в виде сметанообразной массы. Есть варианты развития этого решения, уточняющие содержание и состояние сметанообразного материала.The invention relates to medicine, specifically to therapy and can serve as a starting component for the preparation of drugs for various purposes with a therapeutic effect. The proposed technical solution allows you to create the basis of the drug with a uniform and uniform distribution by weight and volume of biologically active substances that have the ability to maintain their activity for a long time. In addition, this technical solution allows you to get the basis of the drug, which can be an independent drug with a high therapeutic effect. Known drug base containing placental material with a liquid. New is that the placental material with the liquid is made in the form of a creamy mass. There are development options for this solution, clarifying the content and condition of the creamy material.
RU94022194/14A 1994-06-10 1994-06-10 Medicinal agent base RU94022194A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU94022194/14A RU94022194A (en) 1994-06-10 1994-06-10 Medicinal agent base

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU94022194/14A RU94022194A (en) 1994-06-10 1994-06-10 Medicinal agent base

Publications (1)

Publication Number Publication Date
RU94022194A true RU94022194A (en) 1996-05-20

Family

ID=48447896

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94022194/14A RU94022194A (en) 1994-06-10 1994-06-10 Medicinal agent base

Country Status (1)

Country Link
RU (1) RU94022194A (en)

Similar Documents

Publication Publication Date Title
US5563153A (en) Sterile topical anesthetic gel
Gesztes et al. Topical anesthesia of the skin by liposome-encapsulated tetracaine
DE69430132T2 (en) PERNASAL COMPOSITION AND PERNASALE PREPARATION CONTAINING IT
ES2116986T3 (en) METAL-PEPTIDE COMPOSITIONS AND COSMETIC METHODS TO STIMULATE HAIR GROWTH.
TW366286B (en) Flavour-masked pharmaceutical compositions
HUP0003583A2 (en) Therapeutic agents containing ibuprofen
ES2060593T3 (en) DRUG CONTRIBUTION SYSTEM.
DE60126433D1 (en) PROCESS FOR PREPARING PHARMACEUTICAL COMPOSITIONS FOR USE WITH WEICHGELATINE FORMULATIONS
DE69521688D1 (en) PHARMACEUTICAL Brewing Preparations Containing Biodegradable Microcapsules For Controlled Release Of Active Ingredients
KR100849916B1 (en) Daily melatonin dosing units
RU99118588A (en) A NEW MEDICINE FOR INHALATION, HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, CONTAINING FORMOTEROL
RU95101385A (en) Products containing g-csf and tnf-binding protein
ATA21888A (en) AGENT WITH DESTROYING EFFECT ON MALIGNE TUMORS, METHOD FOR THE PRODUCTION THEREOF AND PREPARATION FOR USE IN THE THERAPY OF CANCER DISEASES
KR880007073A (en) medicine
DE69737723D1 (en) CONTAINER FOR IONPOPHORETIC ADMINISTRATION OF MEDICAMENTS WITH INHERENT MATERIAL COMPONENTS
KR970032872A (en) Drugs for the treatment of skin damage containing acetylsalicylic acid
RU99118586A (en) A NEW MEDICINE FOR INHALATION HAVING A FILLING VOLUME DENSITY FROM 0.28 TO 0.38 G / ML, CONTAINING TERBUTALINE SULFATE, METHOD FOR PRODUCING AND ITS APPLICATION
FI962056A0 (en) Novel pharmaceutical composition for the preparation of a stable powder containing an active ingredient comprising a combination of acetylsalicylic acid and metoclopramide
SE9301877D0 (en) IN SITU GEL FOR THERAPEUTIC USE
RU94022194A (en) Medicinal agent base
KR100466757B1 (en) Topical preparation for introducing peptidaceous pharmacons in living organisms
RU94022543A (en) Medicinal agent base and a method of its preparing
RU2223101C2 (en) Kit for stimulating labor activity
KR20000029523A (en) Formulation for the treatment and/or prophylaxis of dementia
KR950701216A (en) USE OF REMACEMIDE FOR THE TREATMENT OF PARKINSON'S DISEASE